Kevin Rooney started The Beacon Consulting Group after successfully building an extensive track record of successful sales and marketing leadership roles over a 19 year period in the biopharmaceutical industry. He successfully launched products into the anesthesia, cardiovascular, and infectious disease therapeutic areas, and has managed products through the end of their respective lifecycles. He has built both marketing and sales teams, and has led teams of 2 and 200. His two key areas of strength are strategic agility and leadership of teams.

Most recently, Kevin was the vice president, sales and marketing for MedImmune's oncology division, where he had strategic oversight of the sales and marketing organization for Ethyol, as well as the development of an extensive pipeline of targeted agents in oncology. Prior to this, he was the senior director of marketing for Synagis, MedImmune’s $1.2B monoclonal antibody for prevention of respiratory infections in preterm infants. 

Prior to joining MedImmune in July 2003, he worked for Bristol-Myers Squibb Company, where he held a number of increasingly responsible positions in both sales and marketing management, including: leading the launch of a quinolone antibiotic, launching a novel antihypertensive, and building a large sales team in the CNS therapeutic area. Kevin also held marketing positions at Glaxo Wellcome Inc. and Burroughs Wellcome Company, and sold for The Upjohn Company. He received his master's degree in management from Northwestern University and his bachelor's degree from the University of Virginia. Kevin serves on the board of directors of GenVec, Inc., and the Board of Trustees of the National Foundation for Infectious Disesase.

By successfully leading teams across specialty areas from primary care to cardiovascular to oncology, and from prescription-based products to hospital-based to specialty-based biologics, he has built a breadth of experience to share with marketers in any specialty. He specializes in helping strategic marketers build grounded, market-based strategic plans, and build the coalitions necessary to see those plans executed across an organization.